The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Gazizova V.P.

Chazov National Medical Research Centre of Cardiology

Vlasova E.E.

Chazov National Medical Research Center of Cardiology

Dzybinskaya E.V.

Chazov National Medical Research Centre of Cardiology

Tabakiyan E.A.

Chazov National Medical Research Centre of Cardiology

Mershin K.V.

Chazov National Medical Research Centre of Cardiology

Gazizov V.V.

Chazov National Medical Research Centre of Cardiology

Vasiliev V.P.

Chazov National Medical Research Center of Cardiology

Shiryaev A.A.

Chazov National Medical Research Center for Cardiology

Akchurin R.S.

Chazov National Medical Research Center for Cardiology

Coronary artery bypass surgery with aortic valve replacement in a patient with heparin-induced thrombocytopenia

Authors:

Gazizova V.P., Vlasova E.E., Dzybinskaya E.V., Tabakiyan E.A., Mershin K.V., Gazizov V.V., Vasiliev V.P., Shiryaev A.A., Akchurin R.S.

More about the authors

Journal: Russian Cardiology Bulletin. 2024;19(1): 73‑78

Read: 1236 times


To cite this article:

Gazizova VP, Vlasova EE, Dzybinskaya EV, et al. . Coronary artery bypass surgery with aortic valve replacement in a patient with heparin-induced thrombocytopenia. Russian Cardiology Bulletin. 2024;19(1):73‑78. (In Russ.)
https://doi.org/10.17116/Cardiobulletin20241901173

Recommended articles:
Left ante­rior descending artery and diagonal branch bypass in multiple-vessel coro­nary artery disease. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(6):646-650
Radionuclide methods in analysis of myocardial perfusion and meta­bolic acti­vity. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2024;(4):12-19
Reclassification of ischemic heart disease epidemiological criteria. Russian Journal of Preventive Medi­cine. 2024;(12):61-68

References:

  1. Vasiliev SA, Gorgidze LA, Moiseeva TN, Al’-Radi LS, Zozulya NI, Sokolova MA, Mazurov AV. heparin-induced thrombocytopenia (review). Aterotromboz. 2019;(1):99-114. (In Russ.). https://doi.org/10.21518/2307-1109-2019-1-99-114
  2. Pirogov AL. Heparin induced thrombocytopenia in cardiovascular surgery. pathogenesis, diagnostics and correction methods. Complex Issues of Cardiovascular Diseases. 2014;(4):95-103. (In Russ.).
  3. Koster A, Dyke CM, Aldea G, Smedira NG, McCarthy HL, Aronson S, Hetzer R, Avery E, Spiess B, Lincoff AM. Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial. Annals of Thoracic Surgery. 2007;83(2):572-577.  https://doi.org/10.1016/j.athoracsur.2006.09.038
  4. Koster A, Spiess B, Chew DP, Krabatsch T, Tambeur L, DeAnda A, Hetzer R, Kuppe H, Smedira NG, Lincoff AM. Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. American Journal of Cardiology. 2004;93(3):356-359.  https://doi.org/10.1016/j.amjcard.2003.10.021
  5. Dyke CM, Smedira NG, Koster A, Aronson S, McCarthy HL 2nd, Kirshner R, Lincoff AM, Spiess BD. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study. Journal of Thoracic and Cardiovascular Surgery. 2006;131(3):533-539.  https://doi.org/10.1016/j.jtcvs.2005.09.057
  6. Pokutnev AP, Efremushkin AG, Kosoukhov AP, Duda AI, Efremushkina AA, Bendrikov OA. The first experience of application of inhibitor bivalirudin direct trombin during coronary bypass surgery under conditions of extracorporeal circulation in altay regional cardiologic dispansary. Complex Issues of Cardiovascular Diseases. 2015;(1):81-85. (In Russ.). https://doi.org/10.17802/2306-1278-2015-1-81-85
  7. Cuker A, Arepally GM, Chong BH, Cines DB, Greinacher A, Gruel Y, Linkins LA, Rodner SB, Selleng S, Warkentin TE, Wex A, Mustafa RA, Morgan RL, Santesso N. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Advances. 2018;2(22):3360-3392. https://doi.org/10.1182/bloodadvances.2018024489
  8. Prescribing Protocol SESLHDPR/711 Bivalirudin for Heparin induced Thrombocytopenia (HIT), 2022.
  9. Ahmed I, Majeed A, Powell R. Heparin induced thrombocytopenia: diagnosis and management update. Postgraduate Medical Journal. 2007;83(983):575-582.  https://doi.org/10.1136/pgmj.2007.059188

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.